89bio (NASDAQ:ETNB) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.69) by 30.43 percent. This is a 63.08 percent increase over losses of $(1.30) per share from the same period last year.
Piper Sandler Maintains Neutral on Block, Lowers Price Target to $84
Piper Sandler analyst Christopher Donat maintains Block (NYSE:SQ) with a Neutral and lowers the price target from $105 to $84.